• 1
    Meyer zum Büschenfelde K-H, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology 1990; 12: 354362.
  • 2
    Homberg J-C, Abraf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, et al. Chronic active hepatitis associated with antiliver/kidney micro-some antibody type I:a second type of “autoimmune hepatitis.” Hepatology 1987; 7: 13331339.
  • 3
    Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest 1989; 82: 10661072.
  • 4
    Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a sort linear sequence in P450IID6, a cytochrome P-450 monoox-ygenase. J Clin Invest 1991; 88: 13701378.
  • 5
    Todros L, Touscoz G, Urso ND, Durazzo M, Albano E, Poli G, Baldi M, et al. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). J Hepatol 1991; 13: 128131.
  • 6
    Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta A, Zauli D, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258259.
  • 7
    Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16: 630636.
  • 8
    Eggink HF, Houthoff HJ, Huhema S, Gips CH, Poppema S. Cellular and humoral immune reactions in chronic active liver disease. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin Exp Immunol 1982; 50: 1724.
  • 9
    Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15: 572577.
  • 10
    Dienes HP, Hütteroth T, Hess G, Meuer SC. Immunelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology 1987; 6: 13171325.
  • 11
    Löhr HF, Schlaak J, Fleischer B, Dienes HP, Meyer zum Büschenfelde K-H, Gerken G. Phenotypical characterisation and cytokine release analysis of peripheral blood and liver-infiltrating T cells from of patients with chronic hepatitis. Liver 1994; 14: 161166.
  • 12
    Schlaak JF, Löhr HF, Gallati H, Meyer zum Büschenfelde K-H, Fleischer B. Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 1993; 94: 168173.
  • 13
    Lohr H, Manns M, Kyriatsoulis A, Lohse A, Trautwein C, Meyer zum Biischenfelde K-H, Fleischer B. Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody positive autoimmune chronic active hepatitis. Clin Exp Immunol 1991; 84: 297302.
  • 14
    Manns M, Gerken G, Kyriatsoulis A, Dienes HP, Meyer zum Büschenfelde K-H. Methodology and significance of the detection of liver-kidney-microsomal (LKM) autoantibodies in autoimmune-type chronic active hepatitis. J Clin Lab Anal 1987; 1: 344352.
  • 15
    Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde K-H, Fleischer B. The human asialoglycoprotein receptor (hASGPR) is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 1990; 12: 13141320.
  • 16
    Fleischer B. Non-specific propagation of human antigen-dependent lymphocyte clones. J Immunol Meth 1988; 109: 215219.
  • 17
    Holzmann B, Johnson J. A b̃-galactosidase-linked immunoassay for the analysis of antigens on individual cells. J Immunol Methods 1983; 60: 359367.
  • 18
    Yamamoto AM, Cresteil D, Homberg JC, Alvarez F. Characterization of anti-liver-kidney microsome antibody (anti-LKMl) from hepatitis C virus-positive and -negative sera. Gastroenterology 1993; 104: 17621767.
  • 19
    Loeper J, Descatoire V, Maurice M, et al. Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies. Gastroenterology 1993; 104: 203216.
  • 20
    Trautwein C, Gerken G, Löhr H, Meyer zum Büschenfelde K-H, Manns M. Lack of surface expression for the B cell-autoepitope of cytochrome P450IID6 evidenced by flow cytometry. Z Gastroenterol 1993; 31: 225230.
  • 21
    Meyer zum Büschenfelde K-H, Lohse AW, Gerken G, Treichel U, Löhr HF, Mohr H, Grob̃e A, et al. The role of auto immunity in hepatitis C virus infection. J Hepatol 1995; 22 (suppl 1): 9396.
  • 22
    Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology 1990; 12: 224232.
  • 23
    Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde K-H, Fleischer B. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 1992; 88: 4549.
  • 24
    Löhr H, Fleischer B, Gerken G, Yeaman SJ, Meyer zum Büschenfelde K-H, Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehy-drogenase complex. J Hepatol 1993; 18: 322327.
  • 25
    Michel G, Ritter A, Gerken G, Meyer zum Biischenfelde K-H, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267269.
  • 26
    Mishiro S, Takeda K, Hoshi Y, Yoshikawa A, Gotanda T, Itoh Y. An auto-antibody cross-reactive to hepatitis C virus core and a host nuclear antigen. Autoimmunity 1991; 10: 269271.
  • 27
    Löhr HF, Gerken G, Michel G, Braun HB, Meyer zum Büschenfelde K-H. In vitro secretion of anti-GOR and anti-HCV antibodies in patients with chronic hepatitis C. Gastroenterology 1994; 107: 14431448.
  • 28
    Townsend AR, Rothbard J, Gotch JM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959964.
  • 29
    Long EO. Intracellular traffic and antigen processing. Immunol Today 1989; 10: 232235.
  • 30
    Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 3438.
  • 31
    Cherwinski HM, Schumacher JH, Brown KD. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166: 12291244.
  • 32
    Jones EA, Hamberg S, Ohara J. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med 1987; 166: 17741787.
  • 33
    Romagnani S. Induction of Th1 and Th2 responses: a key role for the natural immune response? Immunol Today 1992; 13: 379381.
  • 34
    Arnold B, Schönrich G, Hämmerling GJ. Multiple levels of peripheral tolerance. Immunol Today 1993; 14: 1214.
  • 35
    von Boehmer H, Kisielow P. Lymphocyte lineage commitment: instruction versus selection. Cell 1993; 73: 207208.
  • 36
    Cohen IR, Lohse AW. Physiology and pathophysiology of autoimmunity. Semin Liver Dis 1991; 11: 183186.
  • 37
    Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encepha-lomyelitis. Science 1989; 239: 181183.
  • 38
    Sun D, Quin Y, Chluba J, Epplen JT, Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988; 332: 842844.
  • 39
    Lohse AW, Mor F, Karin N, Cohen IR. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989; 244: 820822.
  • 40
    Lohse AW, Cohen IR. Mechanisms of resistance to autoimmune disease induced by T cell vaccination. Autoimmunity 1991; 9: 119121.